Press Release |
|||
Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual MeetingApril 23, 2009 - Santa Clara, CA, USALumenis Inc., a subsidiary of Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced today at the American Urological Association’s (AUA) annual show the introduction of a Holmium Laser Enucleation of the Prostate (HoLEP) training simulator and the PolyScope Disposable Ureteroscope(1) , a new flexible scope with enhanced vision and flexibility. These items support Lumenis’ continued commitment to new technology and training that advance the medical laser community. Computer-Guided Interactive HoLEP SimulatorThe abundance of clinical evidence suggests that HoLEP provides superior outcomes and long term durability in treating Benign Prostatic Hyperplasia (BPH) of all gland sizes(2). There has been increasing interest from physicians to learn HoLEP. Dr. James Lingeman, Clinical Professor of Urology, Indiana University School of Medicine, stated, “The HoLEP simulator is the future of surgical training. This learning approach allows physicians to practice the procedure and first achieve a standard level of competence before operating live. This new training technology will benefit physicians and patients alike.” PolyScope Disposable Ureteroscope(1)Lumenis will also display the PolyScope Disposable Ureteroscope at the AUA. Dr. Markus Bader, University of Munich, will present his initial experience with the PolyScope, and discuss scope utility and impact on clinical practice. Expert Physicians to Present in the Lumenis Booth at the AUA MeetingExperienced thought-leading physicians will be at the Lumenis booth to present HoLAP and HoLEP and their own experiences using PowerSuite and PolyScope, including Drs. Mitchell Humphreys, Mayo Clinic-Scottsdale, Surendra Kumar, Oakwood Annapolis Hospital, Markus Bader, LMU University of Munich, and Scott Hubosky, Thomas Jefferson University. Presentations are scheduled throughout the duration of the AUA meeting. For a complete list of speaker presentations and other Lumenis events, visit Lumenis booth #4236 at the American Urology Association meeting in the McCormick Place Convention Center, April 25-30, 2009. Or visit www.GetPowerSuite.com to see a complete presentation schedule and register for Lumenis events. About VersaPulse PowerSuiteThe PowerSuite laser system, the first holmium laser cleared by the FDA for treatment of Benign Prostatic Hyperplasia (BPH), is also effective for surgical removal of stones, tumors and strictures. It offers a comprehensive solution for physicians and their patients. For more information about VersaPulse PowerSuite laser, log onto: www.surgical.lumenis.com About LumenisLumenis is Israel’s largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com. For further information contact:Michelle Maydan Lumenis®, its logo, VersaPulse® PowerSuite™ and VersaCut™ Morcellator are trademarks or registered trademarks of the Lumenis Group of Companies. (1) PolyScope is not released for sale in the USA (2) 2007, Ehab A. Elzayat, Mostafa M. Elhilali, European Urology, Holmium Laser Enucleation of the Prostate (HoLEP): Long-Term Results, Reoperation Rate, and Possible Impact of the Learning Curve |
|||
| ©2010 Lumenis Surgical | | |||